
Effects of PDE-5 inhibitors, active surveillance among localized prostate cancer topics
Studies examining the post-prostatectomy effects of phosphodiesterase type-5 inhibitors and those discussing active surveillance are among the key papers in localized prostate cancer to be presented at this year's AUA annual meeting, according to Leonard G. Gomella, MD.
This article is part of the


Dr. GomellaStudies examining the post-prostatectomy effects of phosphodiesterase type-5 inhibitors and those discussing active surveillance are among the key papers in localized prostate cancer to be presented at this year's AUA annual meeting, according to Leonard G. Gomella, MD, professor and chairman of urology at Thomas Jefferson University, Philadelphia.
Other noteworthy research in localized prostate cancer from the meeting covers topics such as predictors of favorable urinary outcomes after treatment; comparative effectiveness of robot-assisted and open radical prostatectomy; and use of a 3-D template-guided, transrectal ultrasound-guided system to perform cognitive magnetic resonance image-targeted biopsies.
Specifically, here are Dr. Gomella's top abstract picks on localized prostate cancer from this year's meeting:
Itay Sternberg
Daniar K. Osmonov
Uwe Michi
Matthew Eric Hyndman
Gencay Hatiboglu
Debasish Sundi
Peter Chang
Giorgio Gandaglia
Hamidreza Abdi
Aristeo Lopez
Adam Rensing
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.